Nama Insights

Virtus LifeSci Biotech Products ETF (BBP)

Health · Virtus · NYSE

HealthETF
Virtus LifeSci Biotech Products ETF (BBP) is an exchange-traded fund in the Health category. It has $116.77M in assets, an expense ratio of 0.34% and a 0.00% dividend yield. Under normal market conditions, the fund will invest not less than 80% of its assets in component securities of the index. The index seeks to track the performance of the common stock of U.S. exchange-listed biotechnology companies with at least one drug therapy approved by the U.S. Food and Drug Administration ("FDA") for marketing.
Assets under management$116.77M
Expense ratio0.34%
CategoryHealth
Dividend yield0.00%
NAV$103.60
Fund familyVirtus
ExchangeNYSE

Top holdings

The largest positions Virtus LifeSci Biotech Products ETF reports, by weight.

HoldingNameWeight
MRNA Moderna Inc 3.53%
OMER Omeros Corp 2.70%
IOVA Iovance Biotherapeutics Inc 2.51%
VSTM Verastem Inc 2.21%
PGEN Precigen Inc 1.95%
HALO Halozyme Therapeutics Inc 1.92%
KNSA Kiniksa Pharmaceuticals International PLC Class A 1.90%
ZLAB Zai Lab Ltd ADR Repr 1 Shs 1.87%
RIGL Rigel Pharmaceuticals Inc 1.76%
KURA Kura Oncology Inc 1.75%

Other Health ETFs

Explore live BBP data on Nama Insights →